RxDoctor Payments Data

Parminder Kang, MD

Adult Reconstructive Orthopaedic Surgery · Las Vegas, NVNPI 1720212673

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (41.3%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by UOC USA Inc at 37.9% of the total.

$26,494in general payments, 2019–2025

Across 224 payments — averaging $118.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UOC USA Inc$10K
  • Smith+Nephew$9K
  • Heraeus Medical, LLC.$3K
  • Pacira Therapeutics, Inc.$1K
  • Goode Surgical Inc$696
  • Arthrex$601
  • plus $3K from 21 others
$23,672in research payments, 2019–2025

Across 13 payments — averaging $1820.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Conformis, Inc.$14K
  • Smith+Nephew$10K

What the payments were for

  • Consulting fees$10,95041%
  • Speaking & faculty fees$5,40020%
  • Travel & lodging$1,3105%
  • Food & beverage$8,15031%
  • Education$6833%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in Nevadato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$484,886
Medicare patients
710
Services billed
11,279

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen104$1,147
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen81$742
Meloxicam163$360
Celecoxib11$206
Tramadol Hcl43$103
Ondansetron OdtOndansetron11$86
Oxycodone Hcl11$53
Clindamycin Hcl14$50
Amoxicillin16$33

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →